title: Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
abstract: Antibiotic prophylaxis is recommended for endoscopic procedures if the patient is at high risk of endocarditis or of symptomatic bacteraemia as a consequence of immunosuppression or neutropenia. In most circumstances parenteral amoxycillin and gentamicin are recommended. The addition of parenteral metronidazole is recommended in patients with neutropenia. Vancomycin or teicoplanin are recommended in patients allergic to penicillin. Antibiotic prophylaxis is recommended for all patients undergoing ERCP with evidence of biliary stasis or pancreatic pseudocyst. Oral ciprofloxacin or parenteral gentamicin (or parenteral quinolone, cephalosporin or ureidopenicillin) are recommended for ERCP.
authors.affiliation: Dept. of Gastroenterology, Leigh Infirmary, Lancashire, United Kingdom.
authors.forename: V
authors.initials: V
authors.lastname: Mani
authors.forename: K
authors.initials: K
authors.lastname: Cartwright
authors.forename: J
authors.initials: J
authors.lastname: Dooley
authors.forename: E
authors.initials: E
authors.lastname: Swarbrick
authors.forename: P
authors.initials: P
authors.lastname: Fairclough
authors.forename: C
authors.initials: C
authors.lastname: Oakley
mesh_terms: D000284:Administration, Oral; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D016470:Bacteremia / Q000517:prevention & control; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D002760:Cholangiopancreatography, Endoscopic Retrograde; D002779:Cholestasis / Q000175:diagnosis; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000517:prevention & control; D004697:Endocarditis, Bacterial / Q000209:etiology; D016099:Endoscopy, Gastrointestinal; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D009503:Neutropenia / Q000150:complications; D010192:Pancreatic Pseudocyst / Q000175:diagnosis; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D017334:Teicoplanin / Q000627:therapeutic use; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D008795:Metronidazole; D002939:Ciprofloxacin; D017334:Teicoplanin; D014640:Vancomycin; D000658:Amoxicillin